世界の呼吸器用治療薬市場2020-2025:吸入&点鼻薬、経口、その他

LP Informationが発行した調査報告書(LPI21MA10425)
◆英語タイトル:Global Respiratory Drug Market Growth 2020-2025
◆商品コード:LPI21MA10425
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年1月(※2024年版があります。お問い合わせください。)
◆ページ数:165
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

「呼吸器用治療薬の世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、吸入&点鼻薬、経口、その他など、用途別には、病院、ドラッグストアなどに区分してまとめた調査レポートです。呼吸器用治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・呼吸器用治療薬の世界市場概要(サマリー)
・呼吸器用治療薬の企業別販売量・売上
・呼吸器用治療薬の企業別市場シェア
・呼吸器用治療薬の世界市場規模 2015年-2020年:種類別(吸入&点鼻薬、経口、その他)
・呼吸器用治療薬の世界市場規模 2015年-2020年:用途別(病院、ドラッグストア)
・呼吸器用治療薬の米州市場規模(アメリカ、カナダ、メキシコなど)
・呼吸器用治療薬のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・呼吸器用治療薬の欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・呼吸器用治療薬の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・呼吸器用治療薬市場の成長要因・課題・動向
・呼吸器用治療薬の世界市場予測 2021年-2025年
・呼吸器用治療薬の米州市場予測(アメリカ、カナダ、メキシコなど)
・呼吸器用治療薬のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・呼吸器用治療薬の欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・呼吸器用治療薬の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・呼吸器用治療薬の世界市場予測:種類別(吸入&点鼻薬、経口、その他)
・呼吸器用治療薬の世界市場予測:用途別(病院、ドラッグストア)
・主要企業分析
【レポートの概要】

According to this study, over the next five years the Respiratory Drug market will register a 6.0%% CAGR in terms of revenue, the global market size will reach $ 48220 million by 2025, from $ 38140 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Respiratory Drug business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Respiratory Drug market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Respiratory Drug, covering the supply chain analysis, impact assessment to the Respiratory Drug market size growth rate in several scenarios, and the measures to be undertaken by Respiratory Drug companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Inhalable & Nasal Spray
Oral
Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Drugs Store

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GSK
Sumitomo Dainippon
AstraZeneca
Vertex
Roche
Boehringer Ingelheim
Chiesi
Novartis
Mylan
Teva
Merck
Beximco

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Respiratory Drug consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Respiratory Drug market by identifying its various subsegments.
Focuses on the key global Respiratory Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Respiratory Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Respiratory Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Respiratory Drug Consumption 2015-2025
2.1.2 Respiratory Drug Consumption CAGR by Region
2.2 Respiratory Drug Segment by Type
2.2.1 Inhalable & Nasal Spray
2.2.2 Oral
2.2.3 Others
2.3 Respiratory Drug Consumption by Type
2.3.1 Global Respiratory Drug Consumption Market Share by Type (2015-2020)
2.3.2 Global Respiratory Drug Revenue and Market Share by Type (2015-2020)
2.3.3 Global Respiratory Drug Sale Price by Type (2015-2020)
2.4 Respiratory Drug Segment by Application
2.4.1 Hospital
2.4.2 Drugs Store
2.5 Respiratory Drug Consumption by Application
2.5.1 Global Respiratory Drug Consumption Market Share by Type (2015-2020)
2.5.2 Global Respiratory Drug Value and Market Share by Type (2015-2020)
2.5.3 Global Respiratory Drug Sale Price by Type (2015-2020)

3 Global Respiratory Drug by Company
3.1 Global Respiratory Drug Sales Market Share by Company
3.1.1 Global Respiratory Drug Sales by Company (2018-2020)
3.1.2 Global Respiratory Drug Sales Market Share by Company (2018-2020)
3.2 Global Respiratory Drug Revenue Market Share by Company
3.2.1 Global Respiratory Drug Revenue by Company (2018-2020)
3.2.2 Global Respiratory Drug Revenue Market Share by Company (2018-2020)
3.3 Global Respiratory Drug Sale Price by Company
3.4 Global Respiratory Drug Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Respiratory Drug Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Respiratory Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Respiratory Drug by Regions
4.1 Respiratory Drug by Regions
4.2 Americas Respiratory Drug Consumption Growth
4.3 APAC Respiratory Drug Consumption Growth
4.4 Europe Respiratory Drug Consumption Growth
4.5 Middle East & Africa Respiratory Drug Consumption Growth

5 Americas
5.1 Americas Respiratory Drug Consumption by Countries
5.1.1 Americas Respiratory Drug Consumption by Countries (2015-2020)
5.1.2 Americas Respiratory Drug Value by Countries (2015-2020)
5.2 Americas Respiratory Drug Consumption by Type
5.3 Americas Respiratory Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Respiratory Drug Consumption by Regions
6.1.1 APAC Respiratory Drug Consumption by Regions (2015-2020)
6.1.2 APAC Respiratory Drug Value by Regions (2015-2020)
6.2 APAC Respiratory Drug Consumption by Type
6.3 APAC Respiratory Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Respiratory Drug by Countries
7.1.1 Europe Respiratory Drug Consumption by Countries (2015-2020)
7.1.2 Europe Respiratory Drug Value by Countries (2015-2020)
7.2 Europe Respiratory Drug Consumption by Type
7.3 Europe Respiratory Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Respiratory Drug by Countries
8.1.1 Middle East & Africa Respiratory Drug Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Respiratory Drug Value by Countries (2015-2020)
8.2 Middle East & Africa Respiratory Drug Consumption by Type
8.3 Middle East & Africa Respiratory Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Respiratory Drug Distributors
10.3 Respiratory Drug Customer

11 Global Respiratory Drug Market Forecast
11.1 Global Respiratory Drug Consumption Forecast (2021-2025)
11.2 Global Respiratory Drug Forecast by Regions
11.2.1 Global Respiratory Drug Forecast by Regions (2021-2025)
11.2.2 Global Respiratory Drug Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Respiratory Drug Forecast by Type
11.8 Global Respiratory Drug Forecast by Application

12 Key Players Analysis
12.1 GSK
12.1.1 Company Information
12.1.2 Respiratory Drug Product Offered
12.1.3 GSK Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 GSK Latest Developments
12.2 Sumitomo Dainippon
12.2.1 Company Information
12.2.2 Respiratory Drug Product Offered
12.2.3 Sumitomo Dainippon Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Sumitomo Dainippon Latest Developments
12.3 AstraZeneca
12.3.1 Company Information
12.3.2 Respiratory Drug Product Offered
12.3.3 AstraZeneca Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 AstraZeneca Latest Developments
12.4 Vertex
12.4.1 Company Information
12.4.2 Respiratory Drug Product Offered
12.4.3 Vertex Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Vertex Latest Developments
12.5 Roche
12.5.1 Company Information
12.5.2 Respiratory Drug Product Offered
12.5.3 Roche Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Roche Latest Developments
12.6 Boehringer Ingelheim
12.6.1 Company Information
12.6.2 Respiratory Drug Product Offered
12.6.3 Boehringer Ingelheim Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Boehringer Ingelheim Latest Developments
12.7 Chiesi
12.7.1 Company Information
12.7.2 Respiratory Drug Product Offered
12.7.3 Chiesi Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Chiesi Latest Developments
12.8 Novartis
12.8.1 Company Information
12.8.2 Respiratory Drug Product Offered
12.8.3 Novartis Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Novartis Latest Developments
12.9 Mylan
12.9.1 Company Information
12.9.2 Respiratory Drug Product Offered
12.9.3 Mylan Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Mylan Latest Developments
12.10 Teva
12.10.1 Company Information
12.10.2 Respiratory Drug Product Offered
12.10.3 Teva Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Teva Latest Developments
12.11 Merck
12.11.1 Company Information
12.11.2 Respiratory Drug Product Offered
12.11.3 Merck Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Merck Latest Developments
12.12 Beximco
12.12.1 Company Information
12.12.2 Respiratory Drug Product Offered
12.12.3 Beximco Respiratory Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Beximco Latest Developments

13 Research Findings and Conclusion



【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の呼吸器用治療薬市場2020-2025:吸入&点鼻薬、経口、その他(Global Respiratory Drug Market Growth 2020-2025)]についてメールでお問い合わせはこちらでお願いします。